FDA Advisers: Restrict Some Asthma Drugs

By: Associated Press
By: Associated Press

FDA advisers say some long-acting asthma drugs are too risky.

Medical and scientific advisers to the Food and Drug Administration on Thursday recommended that Foradil and Serevent no longer be used for asthma. But they spared Advair, the top-selling drug in the group.

All the medications contain an ingredient that relaxes muscles around stressed airways. But that may mask symptoms that can trigger life-threatening asthma attacks. Advair contains a second ingredient that reduces inflammation inside breathing passages and may help patients avoid problems.

The FDA's drug safety experts had recommended restrictions, but its respiratory specialists said none were needed. The FDA usually follows the recommendations of its outside advisers.

(Copyright 2008 by The Associated Press. All Rights Reserved.)

KKTV firmly believes in freedom of speech for all and we are happy to provide this forum for the community to share opinions and facts. We ask that commenters keep it clean, keep it truthful, stay on topic and be responsible. Comments left here do not necessarily represent the viewpoint of KKTV 11 News.

If you believe that any of the comments on our site are inappropriate or offensive, please tell us by clicking “Report Abuse” and answering the questions that follow. We will review any reported comments promptly.

powered by Disqus
KKTV 520 E. Colorado Colorado Springs, CO 80903 Office: (719) 634-2844 Fax: (719) 632-0808 News Fax: (719) 634-3741
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 35986389 - kktv.com/a?a=35986389